← Leaderboards
Laura Beretta
University Of Michigan At Ann Arbor
$16,561,253
Attributed
$18,319,699
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,589,703 · 11
By mechanism
P50$16,615,662 · 5
R01$12,936,041 · 5
P30$38,000 · 1
Top collaborators
- Ahmed Kaseb5 shared
- David Fuentes4 shared
- Eugene J Koay4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Xihong Lin$29,087,949
- Omolola Eniola-Adefeso$4,722,113
- Xin Tong$1,683,328
- Samir M Hanash$22,144,784
- Sooryanarayana Varambally$3,620,614
Others in their field
Top investigators on “Primary Carcinoma Of The Liver Cells”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Charles M. Rice · Rockefeller University$25,448,599
- Michael Karin · University Of California, San Diego$20,421,657
- Amit Singal · Ut Southwestern Medical Center$15,537,004
- Raymond T Chung · Massachusetts General Hospital$13,602,946
- Dean W Felsher · Stanford University$13,140,261
Research focus
Primary Carcinoma Of The Liver CellsCirrhosisLiverUnited StatesDiagnosisCohortTumorEarly DiagnosisBaseHigh RiskTexasAffectBiological MarkersReportingIncidencePerformanceNonalcoholic SteatohepatitisPlasmaFibrosisSurveillance StrategyRisk FactorsProspectiveLiver CirrhosisSensitivity And Specificity
Grant awards (49)
Early Detection of Hepatocellular Carcinoma$663,299
R01 · FY2025 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$630,129
R01 · FY2024 · CA · contact PI
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma$2,206,679
P50 · FY2023 · CA · contact PI
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study$1,023,762
P50 · FY2023 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$649,953
R01 · FY2023 · CA · contact PI
Administrative Core$283,020
P50 · FY2023 · CA · contact PI
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma$2,278,344
P50 · FY2022 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$694,288
R01 · FY2022 · CA · contact PI
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study$551,862
P50 · FY2022 · CA · contact PI
Genomics of HCC in the Hispanic population of Texas$353,471
R01 · FY2022 · CA · contact PI
Administrative Core$283,020
P50 · FY2022 · CA · contact PI
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma$2,156,230
P50 · FY2021 · CA · contact PI
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study$671,469
P50 · FY2021 · CA · contact PI
Genomics of HCC in the Hispanic population of Texas$360,685
R01 · FY2021 · CA · contact PI
Administrative Core$290,372
P50 · FY2021 · CA · contact PI
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma$2,332,104
P50 · FY2020 · CA · contact PI
Administrative Core$818,458
P50 · FY2020 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$644,190
R01 · FY2020 · CA · contact PI
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study$575,175
P50 · FY2020 · CA · contact PI
Genomics of HCC in the Hispanic population of Texas$360,685
R01 · FY2020 · CA · contact PI
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma$2,296,647
P50 · FY2019 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$625,481
R01 · FY2019 · CA · contact PI
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study$565,502
P50 · FY2019 · CA · contact PI
Genomics of HCC in the Hispanic population of Texas$349,864
R01 · FY2019 · CA · contact PI
Administrative Core$283,018
P50 · FY2019 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$644,934
R01 · FY2018 · CA · contact PI
Genomics of HCC in the Hispanic population of Texas$390,463
R01 · FY2018 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$611,462
R01 · FY2017 · CA · contact PI
Early Detection of Hepatocellular Carcinoma$645,417
R01 · FY2016 · CA · contact PI
Markers for HCV-related HCC: plasma profiling, targeted strategies and validation$302,718
R01 · FY2013 · CA · contact PI
Markers for HCV-related HCC: plasma profiling, targeted strategies and validation$354,244
R01 · FY2012 · CA · contact PI
Markers for HCV-related HCC: plasma profiling, targeted strategies and validation$354,244
R01 · FY2011 · CA · contact PI
Markers for HCV-related HCC: plasma profiling, targeted strategies and validation$365,200
R01 · FY2010 · CA · contact PI
Novel markers for HCV-related HCC$100,000
R01 · FY2010 · DK · contact PI
Markers for HCV-related HCC: plasma profiling, targeted strategies and validation$365,200
R01 · FY2009 · CA · contact PI
Novel markers for HCV-related HCC$34,521
R01 · FY2009 · DK · contact PI
Novel markers for HCV-related HCC$345,537
R01 · FY2008 · DK · contact PI
Novel markers for HCV-related HCC$353,069
R01 · FY2007 · DK · contact PI
Novel markers for HCV-related HCC$364,095
R01 · FY2006 · DK · contact PI
Role of 4E-BP1 and 4E-BP2 in Translational Control$337,869
R01 · FY2006 · AI · contact PI
Novel markers for HCV-related HCC$376,131
R01 · FY2005 · DK
Role of 4E-BP1 and 4E-BP2 in Translational Control$346,000
R01 · FY2005 · AI
Novel markers for HCV-related HCC$389,250
R01 · FY2004 · DK
Role of 4E-BP1 and 4E-BP2 in Translational Control$212,560
R01 · FY2004 · AI
Role of 4E-BP1 and 4E-BP2 in Translational Control$116,471
R01 · FY2004 · AI
Role of 4E-BP1 and 4E-BP2 in Translational Control$297,201
R01 · FY2003 · AI
Role of 4E-BP1 and 4E-BP2 in Translational Control$297,410
R01 · FY2002 · AI
PKR/ DIFFERENTIAL TRANSLATIONAL CONTROL IN LUPUS T CELLS$0
P30 · FY2002 · AR
PKR/ DIFFERENTIAL TRANSLATIONAL CONTROL IN LUPUS T CELLS$38,000
P30 · FY2001 · AR